Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization

被引：0
|
作者：
Sebastian Kuger
Michael Flentje
Cholpon S. Djuzenova
机构：
[1] University Hospital of Würzburg,Department of Radiation Oncology
来源：
Radiation Oncology | / 10卷
关键词：
AZD6244; NVP-BEZ235; Radiosensitivity; Cell cycle arrest; Apoptosis; Autophagy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Overcoming endocrine resistance in breast cancer: role of the PI3K and the mTOR pathways
    Provenzano, Aaron
    Kurian, Sobha
    Abraham, Jame
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (02) : 143 - 147
  • [42] Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
    Barzegar Behrooz, Amir
    Talaie, Zahra
    Jusheghani, Fatemeh
    Los, Marek J.
    Klonisch, Thomas
    Ghavami, Saeid
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
  • [43] Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
    Park, Sophie
    Chapuis, Nicolas
    Tamburini, Jerome
    Bardet, Valerie
    Cornillet-Lefebvre, Pascale
    Willems, Lise
    Green, Alexa
    Mayeux, Patrick
    Lacombe, Catherine
    Bouscary, Didier
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (05): : 819 - 828
  • [44] Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide
    Prasad, Gautam
    Sottero, Theo
    Yang, Xiaodong
    Mueller, Sabine
    James, C. David
    Weiss, William A.
    Polley, Mei-Yin
    Ozawa, Tomoko
    Berger, Mitchel S.
    Aftab, Dana T.
    Prados, Michael D.
    Haas-Kogan, Daphne A.
    NEURO-ONCOLOGY, 2011, 13 (04) : 384 - 392
  • [45] PI3K and mTOR Signaling Pathways in Cancer: New Data on Targeted Therapies
    Lise Willems
    Jerome Tamburini
    Nicolas Chapuis
    Catherine Lacombe
    Patrick Mayeux
    Didier Bouscary
    Current Oncology Reports, 2012, 14 : 129 - 138
  • [46] PI3K and mTOR Signaling Pathways in Cancer: New Data on Targeted Therapies
    Willems, Lise
    Tamburini, Jerome
    Chapuis, Nicolas
    Lacombe, Catherine
    Mayeux, Patrick
    Bouscary, Didier
    CURRENT ONCOLOGY REPORTS, 2012, 14 (02) : 129 - 138
  • [47] The intersection of the PI3K/mTOR and HIPPO pathways: a potential therapeutic target for medulloblastoma
    Ronecker, Jennifer S.
    Lee, Paul
    Sridhara, Sudeepta
    LaBagnara, Michael
    Murali, Raj
    Jhanwar-Uniyal, Meena
    CANCER RESEARCH, 2016, 76
  • [48] Incidence of oncogenes in PI3K/AKT and MAPK signaling pathways in breast cancer
    Cejalvo, J. M.
    Perez Fidalgo, J. A.
    Bermejo, B.
    Ibarrola-Villaba, M.
    Burgues, O.
    Ribas, G.
    Martinez, M. T.
    Lluch-Hernandez, A.
    ANNALS OF ONCOLOGY, 2015, 26
  • [49] Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis
    Cakir, Mehtap
    Grossman, Ashley B.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (09) : 1121 - 1134
  • [50] Synergistic inhibition of thyroid cancer by suppressing MAPK/PI3K/AKT pathways
    Kandil, Emad
    Tsumagari, Koji
    Ma, Jingjing
    Elmageed, Zakaria Y. Abd
    Li, Xinying
    Slakey, Douglas
    Mondal, Debasis
    Abdel-Mageed, Asim B.
    JOURNAL OF SURGICAL RESEARCH, 2013, 184 (02) : 898 - 906
12345